British Journal of Dermatology

What is new in therapy?
pp. 691-695(5)
Author: Ormerod A.D.

Testing for irritation with a multifactorial approach: comparison of eight non-invasive measuring techniques on five different irritation types
pp. 696-703(8)
Authors: Fluhr J.W.; Kuss O.; Diepgen T.; Lazzerini S.; Pelosi A.; Gloor M.; Berardesca E.

Irritant patch testing with sodium lauryl sulphate: interrelation between concentration and exposure time
pp. 704-708(5)
Authors: Aramaki J.; Löffler C.; Kawana S.; Effendy I.; Happle R.; Löffler H.

Quantitative assessment of primary skin irritants in vitro in a cytotoxicity model: comparison with in vivo human irritation tests
pp. 709-715(7)
Authors: Wilhelm K-P.; Böttjer B.; Siegers C-P.

Mitigation of stress-induced suppression of contact hypersensitivity by odorant inhalation
pp. 716-719(4)
Authors: Hosoi J.; Tanida M.; Tsuchiya T.

Tissue eosinophilia in acute and chronic atopic dermatitis: a morphometric approach using quantitative image analysis of immunostaining
pp. 720-729(10)
Authors: Kiehl P.; Falkenberg K.; Vogelbruch M.; Kapp A.

Atopic eczema and the home environment
pp. 730-736(7)
Authors: Mcnally N.J.; Williams H.C.; Phillips D.R.

Purification of natural antikeratin autoantibodies from normal human serum and their effect on human keratinocytes cultured in vitro
pp. 737-748(12)
Authors: Li C-X.; Wan Y-H.; Chi S-M.; Wang G.; Sun L-C.; Zhang Y-G.; Zhao X-D.; Gao T-W.; Liu Y-F.

Cytochrome P450 4A11 expression in human keratinocytes: effects of ultraviolet irradiation
pp. 749-757(9)
Authors: Gonzalez M-C.; Marteau C.; Franchi J.; Migliore-Samour D.

Localization of sphingomyelin during the development of dorsal and tail epidermis of mice
pp. 758-770(13)
Authors: Yoshida Y.; Yoneda K.; Umeda M.; Ide C.; Fujimoto K.

Immunohistochemical detection for nuclear -catenin in sporadic basal cell carcinoma
pp. 771-777(7)
Authors: Yamazaki F.; Aragane Y.; Kawada A.; Tezuka T.

Cicatricial pemphigoid: IgA and IgG autoantibodies target epitopes on both intra- and extracellular domains of bullous pemphigoid antigen 180
pp. 778-783(6)
Authors: Schmidt E.; Skrobek C.; Kromminga A.; Hashimoto T.; Messer G.; Bröcker E-B.; Yancey K.B.; Zillikens D.

Audit of a melanoma screening day in the U.K.: clinical results, participant satisfaction and perceived value
pp. 784-788(5)
Authors: Holme S.A.; Varma S.; Chowdhury M.M.U.; Roberts D.L.

New sunscreens confer improved protection for photosensitive patients in the blue light region
pp. 789-794(6)
Authors: Moseley H.; Cameron H.; MacLEOD T.; Clark C.; Dawe R.; Ferguson J.

An open study of a lotion formulation to improve tolerance of tacrolimus in facial atopic dermatitis
pp. 795-798(4)
Authors: Sugiura H.; Uehara M.; Hoshino N.; Yamaji A.

Experimental studies on the antiviral agent famciclovir in Behçet's disease symptoms in ICR mice
pp. 799-804(6)
Authors: Sohn S.; Bang D.; Lee E-S.; Kwon H.J.; Lee S.I.; Lee S.

HLA-DQB1 alleles in Italian patients with mucous membrane pemphigoid predominantly affecting the oral cavity
pp. 805-808(4)
Authors: Carrozzo M.; Fasano M.E.; Broccoletti R.; Carbone M.; Cozzani E.; Rendine S.; Roggero S.; Parodi A.; Gandolfo S.

Expression of inducible nitric oxide synthase and nitrotyrosine in borderline leprosy lesions
pp. 809-815(7)
Authors: Schön T.; Hernandez-Pando R.H.; Negesse Y.; Leekassa R.; Sundqvist T.; Britton S.

Vancomycin-induced linear IgA disease with autoantibodies to BP180 and LAD285
pp. 816-820(5)
Authors: Palmer R.A.; Ogg G.; Allen J.; Banerjee A.; Ryatt K.S.; Ratnavel R.; Wojnarowska F.

Anaphylaxis to 5-methoxypsoralen during photochemotherapy
pp. 821-822(2)
Authors: Legat F.J.; Wolf P.; Kränke B.

Bullous and non-bullous ichthyosiform erythroderma associated with generalized pustular psoriasis of von Zumbusch type
pp. 823-825(3)
Authors: Ingen-Housz-Oro S.; Vignon-Pennamen M.D.; Blanchet-Bardon C.

Multiple idiopathic mucocutaneous neuromas: a new entity?
pp. 826-829(4)
Authors: Truchot F.; Grézard P.; Wolf F.; Balme B.; Perrot H.

Eccrine poromas in a patient with mycosis fungoides treated with electron beam therapy
pp. 830-833(4)
Authors: Kurokawa M.; Amano M.; Miyaguni H.; Tateyama S.; Ogata K.; Idemori M.; Setoyama M.

Benign glandular schwannoma
pp. 834-837(4)
Authors: Kim Y-C.; Park H-J.; Cinn Y-W.; Vandersteen D.P.

Correspondence
pp. 838-857(5)